Literature DB >> 7169515

Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.

M Nissim, B Ambrosi, V Bernasconi, G Giannattasio, M A Giovanelli, M Bassetti, U Vaccari, P Moriondo, A Spada, P Travaglini, G Faglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7169515     DOI： 10.1007/BF03350542

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  31 in total

1.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Management of hyperprolactinaemic amenorrhoea.

Authors:  S Franks; H S Jacobs; M G Hull; S J Steele; J D Nabarro
Journal:  Br J Obstet Gynaecol       Date:  1977-04

3.  Bromocriptine suppression of dispersed pituitary lactotrophs from estrogen-pretreated rats: a quantitative electron microscopic study.

Authors:  D J McComb; K Kovacs; R Croxford; J V Milligan
Journal:  Can J Physiol Pharmacol       Date:  1982-02       Impact factor: 2.273

4.  Effects of bromocriptine on CSF proteins and amines in patients with empty sella syndrome, acromegaly and prolactin producing pituitary adenomas.

Authors:  K Brismar; A Sidén; S Werner
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

5.  Treatment of patients with prolactinomas.

Authors:  K v Werder; R Fahlbusch; R Landgraf; C R Pickardt; H K Rjosk; P C Scriba
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

6.  Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.

Authors:  P Chiodini; A Liuzzi; R Cozzi; G Verde; G Oppizzi; D Dallabonzana; B Spelta; F Silvestrini; G Borghi; G Luccarelli; E Rainer; R Horowski
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

7.  Bromocriptine therapy for "nonfunctioning" pituitary tumors.

Authors:  D G Johnston; K Hall; A McGregor; W M Ross; P Kendall-Taylor; R Hall
Journal:  Am J Med       Date:  1981-12       Impact factor: 4.965

8.  Ergot-induced inhibition of pituitary tumor growth in rats.

Authors:  S K Quadri; K H Lu; J Meites
Journal:  Science       Date:  1972-04-28       Impact factor: 47.728

9.  Rapid regression of pituitary prolactinomas during bromocriptine treatment.

Authors:  M O Thorner; W H Martin; A D Rogol; J L Morris; R L Perryman; B P Conway; S S Howards; M G Wolfman; R M MacLeod
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

10.  Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections.

Authors:  H J Geuze; J W Slot; P A van der Ley; R C Scheffer
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539
View more
  6 in total

Review 1.  Medical treatment of pituitary adenomas: effects on tumor growth.

Authors:  A Liuzzi; P G Chiodini; D Dallabonzana; G Oppizzi; G G Verde
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

2.  Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine.

Authors:  J J Orrego; W F Chandler; A L Barkan
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

3.  Long-acting bromocriptine for the acute treatment of large macroprolactinomas.

Authors:  A Zarate; C Moran; R Miranda; M Loyo; M Medina; M E Fonseca
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

4.  Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

Authors:  Alireza M Manuchehri; Thozhukat Sathyapalan; Martin Lowry; Lindsay W Turnbull; Christopher Rowland-Hill; Stephen L Atkin
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

5.  Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.

Authors:  G Verde; G Oppizzi; P G Chiodini; D Dallabonzana; G Luccarelli; A Liuzzi
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

6.  Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis.

Authors:  Xiangming Cai; Junhao Zhu; Jin Yang; Chao Tang; Zixiang Cong; Chiyuan Ma
Journal:  Chin Neurosurg J       Date:  2022-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.